826
Participants
Start Date
November 1, 2022
Primary Completion Date
December 30, 2025
Study Completion Date
December 31, 2025
Tranexamic Acid 100Mg/ml Inj Vial 10ml
Intervention is from the Tranexamic acid to Reduce Infection after Gastrointestinal Surgery: the TRIGS Trial. A multicentre, pragmatic, double-blind, randomised clinical trial will compare the incidence of surgical site infection and red cell transfusion requirements after IV tranexamic acid and placebo in patients undergoing gastrointestinal surgery
Placebo
Normal saline
RECRUITING
Alfred Health, Melbourne
RECRUITING
Alfred Health, Melbourne
Lead Sponsor
Monash University
OTHER
Bayside Health
OTHER_GOV